×
19 May 2021

Roche launches mySugr Pump Control within the mySugr app to simplify insulin pump therapy via smartphone

mySugr now allows control of the Accu-Chek Insight insulin pump directly via smartphone, starting in Austria, bringing more discretion and simplicity to the life of people with diabetes.

06 May 2021

Roche collaborates with Lilly to support people with diabetes on insulin pen therapy

Roche and Lilly will integrate data from Lilly’s connected insulin pen solution into the mySugr app in several countries. Both companies are dedicated to driving new possibilities to ease the complexity of daily decision making for people with diabetes on insulin pen therapy and their healthcare professionals.

07 April 2021

mySugr announces the integration of the NovoPen 6 and NovoPen Echo Plus into the mySugr Logbook

The connection of the Novo Nordisk® smart insulin pens with the mySugr Logbook is now available on iOS in the first country Sweden, with more markets to follow. Bringing data together and setting it into context provides patients and healthcare professionals with a broader picture of the individual diabetes therapy and aims to support its optimization.

Roche integrates the Accu-Chek Insight insulin pump into the automated insulin delivery (AID) system from Diabeloop
01 March 2021

Roche integrates the Accu-Chek Insight insulin pump into the automated insulin delivery (AID) system from Diabeloop

The Accu-Chek Insight insulin pump from Roche will be the first pump with a pre-filled cartridge that can be operated in loop mode. As part of DBLG1 System from Diabeloop, the Accu-Chek Insight insulin pump will enable people with diabetes to better manage their diabetes and improve their time in range.

Roche Logo
11 December 2020

Roche teams up with Diabeloop to advance the management of insulin pump therapy

The partnership will create new opportunities to lower the burden for people with diabetes in daily therapy management and to improve therapy outcomes. By partnering with Diabeloop, Roche steps into the field of automated insulin delivery (AID) representing a milestone in Roche’s strategy of integrated Personalised Diabetes Management (iPDM).

Media Contacts

Journalists are welcome to contact Roche Diabetes Care's media relations team. If you have a general or product-specific enquiry, or any other non-journalistic question, please contact your local Accu-Chek office directly to get guidance.
General contact for Journalists
Contact for Costomers
All Media Contacts